Related Experiment Video
Updated: Apr 15, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy
L Morató1,2,3, M Ruiz1,2,3, J Boada4
1Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Abstract:
Oxidative stress and mitochondrial failure are prominent factors in the axonal degeneration process. In this study, we demonstrate that sirtuin 1 (SIRT1), a key regulator of the mitochondrial function, is impaired in the axonopathy and peroxisomal disease X-linked adrenoleukodystrophy (X-ALD). We have restored SIRT1 activity using a dual strategy of resveratrol treatment or by the moderate transgenic overexpression of SIRT1 in a X-ALD mouse model. Both strategies normalized redox homeostasis, mitochondrial respiration, bioenergetic failure, axonal degeneration and associated locomotor disabilities in the X-ALD mice. These results indicate that the reactivation of SIRT1 may be a valuable strategy to treat X-ALD and other axonopathies in which the control of redox and energetic homeostasis is impaired.
Insights
Restoring sirtuin 1 (SIRT1) function in X-linked adrenoleukodystrophy (X-ALD) mice normalized mitochondrial function and reversed axonal degeneration. This suggests SIRT1 reactivation is a promising therapeutic strategy for X-ALD and similar conditions.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Genetics
Background:
- Oxidative stress and mitochondrial dysfunction are key drivers of axonal degeneration in neurological disorders.
- X-linked adrenoleukodystrophy (X-ALD), a peroxisomal disease, is characterized by impaired axonal integrity.
- Sirtuin 1 (SIRT1), a crucial regulator of mitochondrial health, is found to be deficient in X-ALD.
Purpose of the Study:
- To investigate the role of SIRT1 in X-ALD pathogenesis.
- To evaluate the therapeutic potential of restoring SIRT1 activity in a mouse model of X-ALD.
Main Methods:
- Utilized a mouse model of X-linked adrenoleukodystrophy (X-ALD).
- Employed resveratrol treatment and transgenic overexpression to enhance SIRT1 activity.
- Assessed redox homeostasis, mitochondrial respiration, and bioenergetic parameters.
- Evaluated axonal degeneration and locomotor function.
Main Results:
- Both resveratrol treatment and SIRT1 overexpression restored normal redox balance and mitochondrial respiration in X-ALD mice.
- These interventions successfully reversed axonal degeneration and improved associated motor deficits.
- The study confirmed impaired SIRT1 activity in the X-ALD model.
Conclusions:
- Reactivation of SIRT1 is a viable therapeutic approach for X-ALD.
- Targeting SIRT1 may offer a strategy for treating axonopathies with impaired redox and energy homeostasis.
- Restoring mitochondrial function via SIRT1 is crucial for preventing axonal degeneration.
Related Concept Videos
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Lysosomal Hydrolases
Peroxisomes

